Posts

Showing posts from November, 2020
Show all

V18* USA/Moderna COVID Vaccine mRNA-1273 Emergency Approval in the United States

V17/USA/Covid-19 Vaccine NVX-CoV2373 / SARS-CoV-2 Vaccine NVX-CoV2373

V14 England Safety and Immunogenicity of ChAdOx1 nCoV-19 Vaccine Administered in a Prime-Boost Regimen in Young and Old Adults (COV002): A Single-blind, Randomized, Controlled, Phase 2/3 Trial Results

V13 Russia rAd26 and rAd5/ COVID-19 Vaccine

V12* England Safety and Immunogenicity of the ChAdOx1 nCoV-19 COVID-19 Vaccine Against SARS-CoV-2

Image

V11 Next Generation Vaccine Platforms for COVID-19

V10 Vaccines for COVID-19

V9* China Immunogenicity and Safety of a Recombinant Adenovirus Type-5-Vectored COVID-19 Vaccine in Healthy Adults aged 18 years or Older

V8 COVID-19 Vaccine Development and a Potential Nanomaterial Path Forward

V4 COVID and the Immune System: Determining the Parameters of the Immune Response in Covid-19

V3 Moving Towards Rapid COVID Vaccine Development

V2 Ad5 COVID-19 Vaccine/China/The Safety, Tolerability, and Immunogenicity of a recombinant adenovirus type-5 vectored COVID-19 vaccine

V1 Immunological Considerations for COVID-19 Vaccine Strategies